Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shlomo Yanai currently holds 10,120 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shlomo Yanai has been a net seller of PDLI stock. They have purchased $0 and sold $2.1M worth of shares.
Shlomo Yanai's most recent insider trade was on May 6, 2026, when they sold 1,119 shares at $169.93 per share.
Shlomo Yanai serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 39 insider transactions totaling $2.1M over their tenure at the company.
Shlomo Yanai holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Shlomo Yanai has shown a selling trading pattern, with $0 in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shlomo Yanai was on Dec 4, 2019, when they sold $2.1M worth of CBM shares. This transaction involved 35,796 shares at $60.00 per share.
Shlomo Yanai currently owns 10,120 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shlomo Yanai's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shlomo Yanai has 39 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for Shlomo Yanai and 40,000+ other insiders.